Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies.
Ken-Ei SadaKeiji OhashiYosuke AsanoKeigo HayashiMichiko MorishitaHaruki WatanabeYoshinori MatsumotoShouichi FujimotoYoshinari TakasakiKunihiro YamagataShogo BannoHiroaki DobashiKoichi AmanoMasayoshi HarigaiYoshihiro ArimuraHirofumi Makinonull nullPublished in: Arthritis research & therapy (2020)
A reduced initial GC dose with rapid reduction might be required to ensure the safe treatment of elderly AAV patients.